Kala Pharmaceuticals, Inc. (0JQ2.L)
USD 6.03
(-3.51%)
USD 6.03
(-3.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 3.89 Million | 11.24 Million | 6.36 Million | 6.07 Million | - |
| Cost of Revenue | 303 Thousand | 2.56 Million | 4.09 Million | 3.17 Million | 2 Million | 955 Thousand |
| Gross Profit | -303 Thousand | 1.33 Million | 7.14 Million | 3.18 Million | 4.06 Million | -955 Thousand |
| Operating Expenses | 39.15 Million | 82.68 Million | 116.57 Million | 99.42 Million | 92.29 Million | 64.72 Million |
| Selling, General and Administrative Expenses | 20.26 Million | 65.03 Million | 105.06 Million | 81.06 Million | 65.01 Million | 35.43 Million |
| Research and Development Expenses | 18.58 Million | 17.65 Million | 11.51 Million | 18.35 Million | 27.27 Million | 29.29 Million |
| Other Expenses | - | -926 Thousand | 1.31 Million | - | - | - |
| Cost and Expenses | 39.15 Million | 85.24 Million | 120.67 Million | 102.59 Million | 94.29 Million | 64.72 Million |
| Operating Income | -39.15 Million | -81.35 Million | -109.43 Million | -96.23 Million | -88.22 Million | -64.72 Million |
| Interest Expense | 5.81 Million | 7.26 Million | 8.38 Million | 8.58 Million | 8.48 Million | 3.31 Million |
| Income Tax Expense | - | -44.59 Million | 9.69 Million | 7.67 Million | 7.63 Million | 1.29 Million |
| Earnings before Tax | -42.19 Million | -44.82 Million | -142.6 Million | -104.32 Million | -94.34 Million | -66.73 Million |
| Net Income | -42.19 Million | -223 Thousand | -152.29 Million | -112 Million | -101.98 Million | -66.73 Million |
| Earnings Per Share Basic | -17.35 | -0.15 | -116.79 | -106.92 | -149.06 | -124.73 |
| Earnings Per Share Diluted | -17.35 | -0.15 | -116.79 | -106.92 | -149.06 | -124.73 |
| Weighted Average Shares Outstanding | 2.43 Million | 1.52 Million | 1.3 Million | 1.04 Million | 684.19 Thousand | 535.07 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 2.43 Million | 1.52 Million | 1.3 Million | 1.04 Million | 684.19 Thousand | 535.07 Thousand |
| Gross Margin | - | 0.34 | 0.64 | 0.50 | 0.67 | - |
| EBIT Margin | - | -20.97 | -9.52 | -15.05 | -14.14 | - |
| Profit Margin | - | -0.06 | -13.55 | -17.61 | -16.79 | - |
| EBITDA | -36.08 Million | -36.69 Million | -131.95 Million | -92.9 Million | -83.25 Million | -62.46 Million |
| Earnings Before Tax Margin | - | -20.90 | -9.74 | -15.13 | -14.52 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 70 Thousand | - | - | - |
| Cost of Revenue | 61 Thousand | 66 Thousand | 70 Thousand | 303 Thousand | 157 Thousand | 77 Thousand |
| Gross Profit | -61 Thousand | -66 Thousand | - | -303 Thousand | -157 Thousand | -77 Thousand |
| Operating Expenses | 9.57 Million | 11.7 Million | 9.27 Million | 38.85 Million | 10.5 Million | 9.24 Million |
| Selling, General and Administrative Expenses | 4.31 Million | 5.35 Million | 4.55 Million | - | 4.95 Million | 4.96 Million |
| Research and Development Expenses | 5.25 Million | 6.35 Million | 4.71 Million | - | 5.55 Million | 4.27 Million |
| Other Expenses | -980 Thousand | - | -5000.00 | - | -2.16 Million | -119 Thousand |
| Cost and Expenses | 9.63 Million | 11.77 Million | 9.34 Million | 39.15 Million | 10.5 Million | 9.24 Million |
| Operating Income | -9.63 Million | -11.77 Million | -9.34 Million | -39.15 Million | -8.76 Million | -9.59 Million |
| Interest Expense | 1.45 Million | 1.45 Million | 1.46 Million | -5.81 Million | -1.45 Million | 1.41 Million |
| Income Tax Expense | - | 22.72 Thousand | -5.46 Million | - | -79 Thousand | 1.29 Million |
| Earnings before Tax | -9.57 Million | -11.8 Million | -8.62 Million | -42.19 Million | -8.7 Million | -10.41 Million |
| Net Income | -9.57 Million | -11.8 Million | -8.62 Million | -42.19 Million | -8.7 Million | -10.41 Million |
| Earnings Per Share Basic | -3.16 | -4.20 | -3.18 | - | -3.41 | -4.36 |
| Earnings Per Share Diluted | -3.16 | -4.20 | -3.18 | - | -3.41 | -4.36 |
| Weighted Average Shares Outstanding | 3.03 Million | 2.81 Million | 2.71 Million | 2.43 Million | 2.55 Million | 2.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.03 Million | 2.81 Million | 2.71 Million | 2.43 Million | 2.55 Million | 2.38 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | -132.44 | - | - | - |
| Profit Margin | - | - | -123.24 | - | - | - |
| EBITDA | -9.57 Million | -11.7 Million | -9.27 Million | - | -8.76 Million | -8.56 Million |
| Earnings Before Tax Margin | - | - | -133.44 | - | - | - |
JYD
DAC
603177
688800
CMCAU
ATHARVENT